These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9261394)

  • 41. Analysis of the desialidation process of the haemagglutinin protein of influenza B virus: the host-dependent desialidation step.
    Luo C; Nobusawa E; Nakajima K
    J Gen Virol; 2002 Jul; 83(Pt 7):1729-1734. PubMed ID: 12075092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
    Hurt AC; Barr IG; Durrant CJ; Shaw RP; Sjogren HM; Hampson AW
    Commun Dis Intell Q Rep; 2003; 27(4):542-7. PubMed ID: 15508516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice.
    Ferraris O; Kessler N; Lina B
    Antiviral Res; 2005 Oct; 68(1):43-8. PubMed ID: 16125799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutation of neuraminidase cysteine residues yields temperature-sensitive influenza viruses.
    Basler CF; García-Sastre A; Palese P
    J Virol; 1999 Oct; 73(10):8095-103. PubMed ID: 10482558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amino acid residues contributing to the substrate specificity of the influenza A virus neuraminidase.
    Kobasa D; Kodihalli S; Luo M; Castrucci MR; Donatelli I; Suzuki Y; Suzuki T; Kawaoka Y
    J Virol; 1999 Aug; 73(8):6743-51. PubMed ID: 10400772
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influenza type B neuraminidase can replace the function of type A neuraminidase.
    Ghate AA; Air GM
    Virology; 1999 Nov; 264(2):265-77. PubMed ID: 10562491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of influenza H1N1 neuraminidase V116A and I117V mutations on NA activity and sensitivity to NA inhibitors.
    Adams SE; Lee N; Lugovtsev VY; Kan A; Donnelly RP; Ilyushina NA
    Antiviral Res; 2019 Sep; 169():104539. PubMed ID: 31228489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact on antiviral resistance of E119V, I222L and R292K substitutions in influenza A viruses bearing a group 2 neuraminidase (N2, N3, N6, N7 and N9).
    Gaymard A; Charles-Dufant A; Sabatier M; Cortay JC; Frobert E; Picard C; Casalegno JS; Rosa-Calatrava M; Ferraris O; Valette M; Ottmann M; Lina B; Escuret V
    J Antimicrob Chemother; 2016 Nov; 71(11):3036-3045. PubMed ID: 27432605
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses.
    Hurt AC; Barr IG; Komadina N; Hampson AW
    Virus Res; 2004 Jul; 103(1-2):79-83. PubMed ID: 15163493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The 2nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin-neuraminidase-receptor balance.
    Du W; Guo H; Nijman VS; Doedt J; van der Vries E; van der Lee J; Li Z; Boons GJ; van Kuppeveld FJM; de Vries E; Matrosovich M; de Haan CAM
    PLoS Pathog; 2019 Jun; 15(6):e1007860. PubMed ID: 31181126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The neuraminidases of MDCK grown human influenza A(H3N2) viruses isolated since 1994 can demonstrate receptor binding.
    Mohr PG; Deng YM; McKimm-Breschkin JL
    Virol J; 2015 Apr; 12():67. PubMed ID: 25896455
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors.
    Sauerbrei A; Haertl A; Brandstaedt A; Schmidtke M; Wutzler P
    Med Microbiol Immunol; 2006 Jun; 195(2):65-71. PubMed ID: 16059699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Substrate, inhibitor, or antibody stabilizes the Glu 119 Gly mutant influenza virus neuraminidase.
    Sahasrabudhe A; Lawrence L; Epa VC; Varghese JN; Colman PM; McKimm-Breschkin JL
    Virology; 1998 Jul; 247(1):14-21. PubMed ID: 9683567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant.
    Porotto M; Greengard O; Poltoratskaia N; Horga MA; Moscona A
    J Virol; 2001 Aug; 75(16):7481-8. PubMed ID: 11462020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir.
    Buxton RC; Edwards B; Juo RR; Voyta JC; Tisdale M; Bethell RC
    Anal Biochem; 2000 May; 280(2):291-300. PubMed ID: 10790313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
    Kwon JJ; Choi WS; Jeong JH; Kim EH; Lee OJ; Yoon SW; Hwang J; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Gen Virol; 2018 Mar; 99(3):292-302. PubMed ID: 29493493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir.
    Barnett JM; Cadman A; Burrell FM; Madar SH; Lewis AP; Tisdale M; Bethell R
    Virology; 1999 Dec; 265(2):286-95. PubMed ID: 10600600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.
    Burnham AJ; Armstrong J; Lowen AC; Webster RG; Govorkova EA
    J Virol; 2015 Apr; 89(8):4575-87. PubMed ID: 25673705
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza.
    Macdonald SJ; Cameron R; Demaine DA; Fenton RJ; Foster G; Gower D; Hamblin JN; Hamilton S; Hart GJ; Hill AP; Inglis GG; Jin B; Jones HT; McConnell DB; McKimm-Breschkin J; Mills G; Nguyen V; Owens IJ; Parry N; Shanahan SE; Smith D; Watson KG; Wu WY; Tucker SP
    J Med Chem; 2005 Apr; 48(8):2964-71. PubMed ID: 15828835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site.
    Gubareva LV; Nedyalkova MS; Novikov DV; Murti KG; Hoffmann E; Hayden FG
    J Gen Virol; 2002 Nov; 83(Pt 11):2683-2692. PubMed ID: 12388803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.